GlassScriptPhysician profile
Raxit R Patel
NPI 1417118605
$6,702.14
in general payments reported to CMS, 2019-2025
43 companies · $2,038 in 2025
The $2,038 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $697 · 2021: $734 · 2022: $725 · 2023: $812 · 2024: $825 · 2025: $2,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,527 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,526.92 |
| Education | $147.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,005.98 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $821.76 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Actelion Pharmaceuticals US, INC. | $516.40 | 2019-2025 | Opsumit, Uptravi |
| Grifols USA, LLC | $508.69 | 2020-2025 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $468.48 | 2019-2025 | Ofev |
| Genzyme Corporation | $426.06 | 2021-2025 | |
| Electromed, INC. | $307.34 | 2019-2025 | Smartvest |
| Mylan Specialty L.P. | $230.18 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $222.57 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $207.80 | 2020-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $183.54 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $140.62 | 2021 | |
| Merck Sharp & Dohme LLC | $131.84 | 2019-2025 | Winrevair |
| Philips North America LLC | $126.04 | 2019-2022 | |
| Inogen, INC. | $117.61 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raxit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.